Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Humanized monoclonal antibody hMN-14 targeted to carcinoembryonic antigen data

IMMU (Morris Plains, N.J.) reported preliminary results in 17 patients, showing

Read the full 116 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE